In estrogen receptor-positive MCF-7 breast cancer cells, overexpression of ADAM12-L promoted estrogen-independent proliferation, and this effect of ADAM12-L was linked to elevated EGFR activation [9]. The gene discussed is EGFR; the disease is breast carcinoma.